![](https://investorshub.advfn.com/uicon/477075.png?cb=1499007485)
Tuesday, March 06, 2018 12:14:44 PM
"We believe in the core technology, and have solid plans to use it going forward. We did a voluntary recall in 2014 for the Diabecline branded antibiotic swab because the formulation was causing deterioration of the swab tip. We will not have that configuration going forward, but will be using and protecting the technology."
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=129232062
Actually NOT very likely because the formula didn’t work before and has been changed ... NO INFRINGEMENT OCCURED ... anyone can take a widget or gadget and teek it to a different product all day every day and patent it ... Keough doesn’t own any rights to the ingredients
FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM